COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,705 Articles (22,913 medRxiv, 8,792 bioRxiv)

Most recent first Previous |  Page 190: Articles 1891-1900  | Next

Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: primary day-28 analysis of a phase 2/3 open-label study
Alves, K., Kouassi, A., Plested, J. S., Kalkeri, R., Smith, K., Kaba, M., Nelson, J., Zhu, M., Cloney-Clark, S., Cai, Z., Mallory, R., Noriega, F.
10.1101/2024.10.25.24316129 — Posted: 2024-11-01
Spatial Patterns of COVID-19 Mortality: Examining Socioeconomic Determinants in U.S. Counties Using Cluster Analysis
Wardrup, R. R.
10.1101/2024.10.30.24316443 — Posted: 2024-11-01
RGFSAMNet: An interpretable COVID-19 detection and classification by using the deep residual network with global feature fusion and attention mechanism
Karim, S. M. R. U., Bala, D., Rasul, R. A., Goggins, S.
10.1101/2024.10.30.24316451 — Posted: 2024-11-01
Quality of vaccination-induced T cell responses is conveyed by polyclonality and high, but not maximum, antigen receptor avidity
Kocher, K., Drost, F., Tesfaye, A. M., Moosmann, C., Schuelein, C., Grotz, M., D'Ippolito, E., Graw, F., Spriewald, B., Busch, D. H., Bogdan, C., Tenbusch, M., Schubert, B., Schober, K.
10.1101/2024.10.30.620795 — Posted: 2024-10-31
Antigenic imprinting dominates humoral responses to new variants of SARS-CoV-2 in a hamster model of COVID-19
Degryse, J., Maas, E., Lassauniere, R., Geerts, K., Kumpanenko, Y., Weynand, B., Maes, P., Neyts, J., Thibaut, H. J., Alpizar, Y. A., Dallmeier, K.
10.1101/2024.10.30.621174 — Posted: 2024-10-31
Participant experience of Scottish Ballets dance-based long COVID support programme: A mixed methods study
Philip, K. E. J., Burton, A., Lewis, A., Buttery, S. C., Williams, P. J., Polkey, M. I., Fancourt, D., Hopkinson, N. S.
10.1101/2024.10.28.24316302 — Posted: 2024-10-30
A comparative study of multidrug resistant bacteria (MDRB) isolated from various patients in different wards of a hospital during post Covid-19
Ojha, A., Figueiredo, D., Khan, S.
10.1101/2024.10.25.24315976 — Posted: 2024-10-30
Deep generative design of neutralizing nanobodies againstSARS-CoV-2 variants
Huo, L., Tian, T., Xu, Y., Qin, Q., Jiang, X., Huang, Q.
10.1101/2024.10.29.620982 — Posted: 2024-10-30
How the COVID-19 pandemic affected lifestyle and wellbeing factors associated with dementia risk in older adults with Subjective Cognitive Decline and Mild Cognitive Impairment participating in the APPLE-Tree (Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce) in England
Wright, A. M., Demnitz-King, H., Burton, A., Morse, R. M., Alberts, S., Kenten, C., Jeraldo, R. I. E., Poppe, M., Barber, J., Cooper, C.
10.1101/2024.10.28.24316260 — Posted: 2024-10-29
Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain in an outpatient household cohort
Churiwal, M., Tompkins, K., Streeter, G., Litel, C., Mason, S., Lin, K., Muller, M., Chhetri, S., Belvin, T., Basham, C., Whittelsey, M., Rapp, T., Premkumar, L., Cerami, C., Lin, J. T.
10.1101/2024.10.27.24316219 — Posted: 2024-10-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).